Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Altimmune (ALT) Net Income - Minority (2016 - 2017)

Altimmune (ALT) has disclosed Net Income - Minority for 2 consecutive years, with -$9.3 million as the latest value for Q4 2017.

  • Quarterly Net Income - Minority fell 154776.81% to -$9.3 million in Q4 2017 from the year-ago period, while the trailing twelve-month figure was -$9.3 million through Dec 2017, down 154776.81% year-over-year, with the annual reading at -$9.3 million for FY2017, 154776.81% down from the prior year.
  • Net Income - Minority for Q4 2017 was -$9.3 million at Altimmune, down from -$5993.0 in the prior quarter.
  • The five-year high for Net Income - Minority was -$5993.0 in Q4 2016, with the low at -$9.3 million in Q4 2017.